Distinct Genomic Landscapes of Gastroesophageal Adenocarcinoma Depending on PD-L1 Expression Identify Mutations in RAS-MAPK Pathway and TP53 as Potential Predictors of Immunotherapy Efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology